Rajkovic Aleksandar 4

What Happened
Aleksandar Rajkovic, a director of Bionano Genomics, was granted a derivative equity award of 9,149 shares on 2026-05-14. The shares were issued at $0.00 (no cash paid) and are recorded as derivative securities on the Form 4.

Key Details

• Transaction date: 2026-05-14; filing date: 2026-05-14 (timely filing).
• Type/code: Award/Grant (A); 9,149 shares; price per share: $0.00.
• Shares owned after the transaction: not specified in the provided filing details.
• Vesting (footnote): shares vest in equal monthly installments over 12 months from the grant date, but will be fully vested by the Company's next annual stockholder meeting if not already vested; vesting also accelerates upon a Change of Control. Vesting is subject to the holder’s continuous service per the 2018 equity incentive plan.

Context
This is a standard director equity grant (a derivative award subject to vesting), not an open-market purchase or sale. Because the shares are subject to time-based vesting, they are not immediately transferable and represent potential future ownership if vesting conditions are met. The filing shows no cash exchanged and was submitted the same day as the grant.